Has Heather Bejenaru, MD received payments from drug or device companies?

Yes. Drug and device makers reported $7,060 in general payments to Heather Bejenaru, MD across 231 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Heather Bejenaru, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Heather Bejenaru, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Heather Bejenaru, MD

Family Medicine · Kihei, HINPI 1154498665

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.7% of the total across 231 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by AbbVie at 36.0% of the total. Among family medicine clinicians in HI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,060in general payments, 2019–2025

Across 231 payments — averaging $30.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$3K
Regeneron Healthcare Solutions, Inc.$1K
Galderma Laboratories, L.p.$598
Arcutis Biotherapeutics, Inc.$454
Lilly USA, LLC$434
E.r. Squibb & Sons, L.L.C.$344
plus $2K from 14 others

What the payments were for

Food & beverage$7,042100%
Education$180%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	89	$2,538
Regeneron Healthcare Solutions, Inc.	28	$1,021
Galderma Laboratories, L.p.	11	$598
Arcutis Biotherapeutics, Inc.	11	$454
Lilly USA, LLC	16	$434
E.r. Squibb & Sons, L.L.C.	13	$344
Sun Pharmaceutical Industries Inc.	11	$304
LEO Pharma Inc.	12	$258
Amgen(2 entities)	9	$220
UCB, Inc.	6	$185
Incyte Corporation	2	$130
AstraZeneca	1	$117
Johnson & Johnson	5	$100
Sanofi	3	$76
Novartis	4	$74
Organon	3	$69
Pfizer	2	$43
Ortho Dermatologics, A Division Of Bausch Health US, LLC	3	$42
Dermavant Sciences, Inc.	1	$31
Bristol Myers Squibb	1	$23

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

NEMLUVIO$450
Skyrizi$339
ZORYVE$259
Rinvoq$224
Humira$214
DUPIXENT$125
SAPHNELO$117
OPZELURA$102

How this compares

$7,060 in reported general payments places this provider in the 90th percentile of 376 family medicine providers in Hawaii.

See all family medicine providers in Hawaii →

Medicare billing

Part B allowed, 2024

$254,673

Medicare patients

537

Services billed

3,284

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Fluorouracil	71	$4,986
Tacrolimus	25	$4,491
Mupirocin	387	$3,076
Clobetasol Propionate	42	$2,616
Calcipotriene	16	$1,901
Ketoconazole	76	$1,625
ValacyclovirValacyclovir Hcl	41	$1,178
Halobetasol Propionate	33	$1,148
Imiquimod	23	$1,004
Metronidazole	15	$761
Clindamycin Phosphate	18	$538
Triamcinolone Acetonide	85	$438
Clotrimazole	24	$412
Doxycycline Hyclate	29	$403
Nystatin	24	$363

Paid to pharmacies, not to this prescriber.

Other family medicine in Kihei

Brian StolleyKihei$126K
Annelle OnishiKihei$10K
Burton FeinermanKihei$3K
Vicente RamoHonolulu$34K
Edward AlqueroWaipahu$24K
Noelani HobbsWaipahu$23K
Rainier Dennis BautistaLihue$23K
Choon YeoHonolulu$20K
Buddy FesterlingHilo$20K
Roy KogaHilo$20K

See the full list for Hawaii →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →